Faworyt inwestycyjny tow. Balcerowicza dostal wezwanie od
amerykanskiego NIKu.
Sprawa naswietla przewalki z cenami lekow. Do szpitala ma to tyle, ze
zbankrutowal w wyniku oszustw Pfizer i spolki.

m



Wednesday January 9 3:11 AM ET

Wall Street Journal: Pfizer Gets Subpoena

NEW YORK (Reuters) - Pfizer Inc. (NYSE:PFE - news), the world's No. 1
drugmaker, said it had received a subpoena from the U.S. government
and that it had
declined to voluntarily hand over information on drug prices, The Wall
Street Journal reported on Wednesday.

Pfizer, which is one of the few large drug producers not yet hit by
patent expirations on key drugs, said it was afraid about the
confidentiality of some of its information,
the newspaper said in its online edition.

The company and its chief executive Henry McKinnell received the
subpoena from the General Accounting Office (GAO) last week, the
newspaper said. The
subpoena requires a response by Jan. 14, it said.

Ten other drug makers have complied to the request, which is part of a
larger investigation into prices Medicaid pays for prescription drugs,
The Wall Street Journal said.

Spokespeople for Pfizer were not immediately available for comment.

Pfizer said the GAO had rebuffed several suggestions to safeguard the
data's confidentiality, the paper reported.

The newspaper quoted Pfizer's General Counsel Jeffrey Kindler as
saying that the company has ``no interest in an adversarial
relationship with the GAO'' but that ``this
information has the potential to compromise competitive positions in
the marketplace''.

On Tuesday, Pfizer reiterated previous forecasts calling for 2002
profits in line with Wall Street expectations, standing by an
identical announcement made last month.

Pfizer said it comfortable with estimates that 2002 profits will range
from $1.56-$1.60 per share, excluding items.

end